nice news for pharming
Pharming Awarded ?Best Biotechnology Company’ By The World Technology Network
Leiden, The Netherlands, December 2, 2010. Pharming Group NV (“Pharming”) (NYSE Euronext: PHARM) today announced that last night it received the Award for Best Biotechnology Company for 2010 by the World Technology Network (WTN) at the World Technology Summit (November 30-December 1, 2010) in New York City. Pharming has been awarded for “its innovative work on production of life enhancing drugs derived from its transgenic platform, an achievement viewed by the voting committee as one of the greatest likely long-term significant achievements within the science and technology arena.”
The World Technology Awards are presented annually by the WTN at a dinner of its World Technology Summit to individuals and corporations achieving significant, lasting progress in categories pertaining to science, technology, finan ce, IT, design, and many more. The first World Technology Summit and Awards took place on November 12, 1999 in London. Last night’s Awards dinner was held at the Time Life Building in Manhattan and the awards are presented in association with Time, NASDAQ, Fortune, AAAS, Science, NYAS, and The Technology Review.
Sijmen de Vries, Pharming’s CEO, said, “This has been a highly significant year for Pharming with the European approval of our lead product Ruconest for treatment of acute attacks of Hereditary Angioedema. This highly innovative product is produced through Pharming’s proprietary transgenic technology and will be launched this year. Ruconest has been in clinical development with the needs of patients at the forefront of our drive to get this to market. We are delighted to accept this award on behalf of the entire Pharming team as recognition for their commitment and hard work.”
Previous winners have included Alnylam , Advanced Cell Technology, Amyris Biotechnologies, Genencor International, Genentech, International Rice Genome Sequencing Project
